⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NAMS News
NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit
globenewswire.com
NAMSW
NAMS
NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
globenewswire.com
NAMS
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
NAMS
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
NAMS
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in December
globenewswire.com
NAMS
Adm. Craig Faller (Ret.) and Adele Gulfo Elected to Battelle Board of Directors
businesswire.com
HII
VMD
SIGM
ENPRO
TYRA
NAMS
PFE
AZN
RVVT
VTRS
Caristo Chosen by Leading Pharma Company as Worldwide Imaging Core Lab to Measure Coronary Plaque and Inflammation
prnewswire.com
NAMS
Piramal Pharma Solutions und NewAmsterdam Pharma investieren in einen spezialisierten Produktionsbereich, um die Herstellungskapazitäten fester oraler Darreichungsformen am Piramal-Standort in Sellersville, Pennsylvania, zu erweitern USA - Deutsch USA -
prnewswire.com
NAMS
NAMS
Piramal Pharma Solutions et NewAmsterdam Pharma investissent dans une unité dédiée pour améliorer les capacités de production de dosages solides oraux sur le site de Piramal à Sellersville, en Pennsylvanie. USA - Français España - español USA - English
prnewswire.com
NAMS
NAMS